Page last updated: 2024-09-04

leonurine and Fibrosis

leonurine has been researched along with Fibrosis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's4 (66.67)2.80

Authors

AuthorsStudies
Chen, K; Li, Z; Zhu, YZ1
Dai, C; Huang, W; Li, W; Li, X; Liang, G; Luo, W; Shen, S; Wu, G1
Ouyang, J; Pi, D; Wang, R; Xi, T; Yang, J1
Li, D; Li, G; Lv, D; Ouyang, J; Peng, L; Shang, F; Wang, R; Yan, J; Yang, J1
Bo, Y; Cheng, H; Jia, Z; Li, F; Shen, W; Tan, J; Xu, C1
Deng, HY; Gong, QH; Huang, GY; Liu, XH; Pan, LL; Wu, D; Xiong, QH; Zhu, YZ1

Other Studies

6 other study(ies) available for leonurine and Fibrosis

ArticleYear
Leonurine inhibits cardiomyocyte pyroptosis to attenuate cardiac fibrosis via the TGF-β/Smad2 signalling pathway.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Animals; Cardiovascular Diseases; Fibrosis; Isoproterenol; Myocytes, Cardiac; Pyroptosis; Rats; Signal Transduction; Transforming Growth Factor beta

2022
Leonurine attenuates angiotensin II-induced cardiac injury and dysfunction via inhibiting MAPK and NF-κB pathway.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Volume: 108

    Topics: Angiotensin II; Animals; Fibrosis; Heart Failure; Mice; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; NF-kappa B; Rats

2023
The p53/miR-29a-3p axis mediates the antifibrotic effect of leonurine on angiotensin II-stimulated rat cardiac fibroblasts.
    Experimental cell research, 2023, 05-01, Volume: 426, Issue:1

    Topics: Angiotensin II; Animals; Collagen Type I; Fibroblasts; Fibrosis; MicroRNAs; Rats; Tumor Suppressor Protein p53

2023
Leonurine Attenuates Myocardial Fibrosis Through Upregulation of miR-29a-3p in Mice Post-myocardial Infarction.
    Journal of cardiovascular pharmacology, 2021, 02-01, Volume: 77, Issue:2

    Topics: Angiotensin II; Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen; Disease Models, Animal; Fibroblasts; Fibrosis; Gallic Acid; Male; Mice, Inbred C57BL; MicroRNAs; Myocardial Infarction; Myocardium; Transforming Growth Factor beta; Up-Regulation; Ventricular Function, Left; Ventricular Remodeling

2021
Leonurine ameliorates kidney fibrosis via suppressing TGF-β and NF-κB signaling pathway in UUO mice.
    International immunopharmacology, 2015, Volume: 25, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Epithelial-Mesenchymal Transition; Fibrosis; Gallic Acid; Kidney; Kidney Diseases; Mice, Inbred C57BL; NF-kappa B; Protective Agents; Reactive Oxygen Species; Signal Transduction; Transforming Growth Factor beta; Urethral Obstruction

2015
Leonurine (SCM-198) attenuates myocardial fibrotic response via inhibition of NADPH oxidase 4.
    Free radical biology & medicine, 2013, Volume: 54

    Topics: Angiotensin II; Animals; Cells, Cultured; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Fibrosis; Gallic Acid; Leonurus; Male; Matrix Metalloproteinase 2; Myocardial Infarction; Myocardium; NADPH Oxidase 4; NADPH Oxidases; NF-kappa B; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction

2013